(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MNEMO JETS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MNEMO JETS

ST13

US500000079345490

Class

1, 5, 40, 42, 44

Filing

79345490

Registration

7220558

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

03/18/2024

Trademark type

Word

Nice classes

1, 5, 40, 42, 44

Filing date

01/13/2022

Registration date

11/21/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/21/2023

Last transaction

11/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

34

Owner location

FR

Examiner

HERR, JENNA FRANCES

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

M. T. (pessoa física)

Representatives

Jill Anderfuren Lewis Brisbois Bisgaard & Smith LLP

Technical classification

Nice Classes

Class 1Class 5Class 40Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

biological and chemical products for manufacturing and research use in the pharmaceutical industry; chemical reagents for the manufacture of therapeutic immunotherapy solutions

Class 5

pharmaceutical products for use in oncology and immunotherapy; biological and pharmaceutical preparations for the treatment of cancer and tumors; biological and pharmaceutical preparations for cancer and tumor treatment using immunotherapy; therapeutic preparations being solutionsantigenantibodiesT-cells in the nature of preparations for treatment of cancer and tumors; biological materialspreparationsreagents being pharmaceutical products for medical use for the treatment of cancer and tumors; diagnostic preparations for medical purposesantigensantibodiescells for therapeutic use

Class 40

Custom manufacture of pharmaceutical products for therapeutic use in immunotherapy; custom manufacture of therapeutic solutionsantigensantibodiesT cells

Class 42

Scientific research services for medical purposes; scientific research and product developmentantigen identificationscreening and development services; scientific and technological research services in the field of oncology and immunotherapy; scientific laboratory services; providing scientific and medical research information with regard to immunotherapy; scientific research and developmentproviding services for identifyinganalyzingauthenticatingpurifying and developing biological material from a genomic platform; scientific researchepigenetic antigen screening and identification services for therapeutic research purposes; medical researchgenomic and epigenetic characterization services for identifying drug candidates in immunotherapy; providing medical and scientific research informationdesigning algorithms and models for use in scientific and medical research; Providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cellsantigenstissuesgene expressionsgene sequencesgenome annotationsantigen characteristics and immunological responses; Providing temporary use of an online non-downloadable computer software platform for use in forecasting the characteristics of antigens and immunological responses through the use of algorithms

Class 44

providing medical information with regard to immunotherapy

Publications

History of USPTO decisions and trademark events.

33 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/18/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/22/2024

FIMP

FINAL DISPOSITION PROCESSED

02/22/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/21/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/05/2023

PUBO

PUBLISHED FOR OPPOSITION

09/05/2023

GPNX

NOTIFICATION PROCESSED BY IB

09/04/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/16/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/16/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/16/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/02/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

08/02/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/02/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

08/02/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/02/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/07/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

07/07/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/07/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/07/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/06/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/06/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/06/2023

RFNP

REFUSAL PROCESSED BY IB

02/02/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/09/2023

RFRR

REFUSAL PROCESSED BY MPU

01/08/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/26/2022

CNRT

NON-FINAL ACTION WRITTEN

10/25/2022

DOCK

ASSIGNED TO EXAMINER

10/21/2022

MAFR

APPLICATION FILING RECEIPT MAILED

07/26/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/22/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/21/2022

Continuous trademark protection

Get notified about every new filing that threatens MNEMO JETS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.